Axsome Therapeutics (AXSM) PT Raised to $77 at Jefferies on Solid Acquisition Accretion
Tweet Send to a Friend
Jefferies analyst Chris Howerton raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $77.00 (from $71.00) noting that the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
